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Counterfeiting of pharmaceutical products represents 
concerns for both the industry and general public safety. 
Falsification produces losses to companies and poses 
health risks for patients. In order to detect fake 
pharmaceutical tablets, we propose producing film-
coated tablets with gold nanoparticle encoding. These 
coated tablets contain unique polarimetric signatures. 
We present experiments to show that ellipsometric 
optical techniques in combination with machine learning 
algorithms can be used to distinguish among genuine and 
fake samples. To the best of our knowledge this is the 
first report on using gold nanoparticles encoding with 
optical polarimetric classification for anti-counterfeiting 
of pharmaceutical products. © 2016 Optical Society of 
America 
OCIS codes: (100.4998) Pattern recognition, optical security and 
encryption, (260.5430) Polarization, (240.0310) Ellipsometry and 
polarimetry, (150.0150) Machine vision. 
http://dx.doi.org/10.1364/OL.99.099999 
Optical techniques have been suggested for authentication and 
anti counterfeiting [1] mainly by using optically encoded tags. In 
recent years, the use of metal nanoparticles has been present in 
multiple fields of science and technology. In particular, gold 
nanoparticles (AuNP) are widely used in biology and medicine 
since they are considered non-toxic and biocompatible [2-4].  
Multiple applications for AuNP in biomedicine have been 
described. Among many others, AuNP are being used as labeling, 
delivery, heating, or gene-regulating agents. They also play a role in 
photo-responsive therapeutics or as drug carriers [5-6] and, due to 
their particular scattering properties, AuNP can be used in imaging 
diagnostic systems [7-8]. AuNP display interesting scattering and 
polarization properties that depend on the size and form of the 
nanoparticles [9-11]. Nanoparticle structures can be used for 
security and counterfeit applications. Subtle changes in the 
polarimetric signature can be detected and subsequently 
processed using machine learning algorithms. These pattern 
recognitions techniques are able to distinguish among true and 
false classes with high confidence [12-13]. Counterfeiting of 
pharmaceutical products represents a major concern for both the 
industry and the general public [14-18]. These kinds of 
counterfeiting activities produces losses to companies and can 
result in severe health risks for those who take fake medicines 
obtained outside the regulated distribution system. In order to 
detect possible counterfeiting in pharmaceutical tablets (a.k.a. 
pills), we propose producing film-coated tablets with AuNP. Such 
film-coated tablets will become polarimetrically labeled and can 
produce a unique polarimetric signal that enables distinguishing 
among authentic and false classes of tablets. To the best of our 
knowledge this is the first report on using AuNP in pharmaceutical 
products for anti-counterfeiting using polarimetric techniques and 
machine learning classification algorithms.  
This paper is organized as follows: first we describe the 
fabrication process for obtaining AuNP film-coated tablets. Then, 
we review basic polarimetric principles used in the analysis of the 
tablets. Experimental device is also described. Experimental 
results and analysis of data are presented and discussed.  
Flat tablets with a diameter of 10 mm, coated with 
hydroxypropyl methylcellulose (HPMC) were prepared according 
to the formulation presented in Table 1. HMPC is a safe and inert 
product, widely used as excipient in pharmaceutical coatings [19]. 
AuNP were obtained from three commercial solutions (Endor 
Nanotechnologies) with different concentrations: 0.05 mg/ml for 
the 4 nm AuNP, 0.03 mg/ml for the 12 nm samples and 0.01 
mg/ml for the 25 nm nanoparticles. In all cases, dispersity index Đ 
(a measure of heterogeneity of sizes of particles) was close to 1. 
 
Table 1: tablets and coating components 
Tablet 
components: 
Lactose monohydrate  
(Tablettose® 80) 
35% 
 Microcrystalline cellulose  
(Vivapur® 101)  
59% 
 Talc  4% 
 Magnesium stearate   2% 
Tablet coating: Hydroxypropyl methylcellulose 
(HPMC) (Pharmacoat® 606) 
3% 
 Deionized water 97% 
The components of the tablets were weighed and screened 
through a 0.8 mm mesh sieve and subsequently mixed during 30 
minutes in a biconic mixer at a speed of 20 rpm. Then, direct 
compression of the mixture using an eccentric tableting machine 
was carried out. This instrument was adjusted to produce tablets 
with a weight of 270 mg and a hardness of about 100 N. The 4, 12 
and 25 nm AuNP were dispersed in different containers by means 
of mechanical agitation. A fourth group of film-coated tablets was 
produced without nanoparticles. We will refer to them as placebo 
film-coated tablets. The solutions were filtered through a sieve 
0.212 mm wide.  
The film-coated tablets obtained are indistinguishable under 
visual inspection or using conventional image processing 
techniques. Figure 1(a) shows 8 film-coated tablets of the four 
classes as they were mounted in sample holder of the instrument. 
An extra pill, that was not measured, also appears on the image as 
it was used for the initial alignment of the sample holder. A 
schematic of the instrument is shown in Fig. 1(b). Note that tablets 
are isotropic so their orientation does not matter 
.
 
 
Fig. 1. (a) Experimental set up. Film-coated tablets as they 
were mounted in sample holder of the instrument. PEMs are 
the photoelastic modulators. (b) Schematic of the Mueller 
matrix ellipsometer device setup. 
The Mueller matrix used in the analysis is noted as: 
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It provides a complete polarimetric description of the sample. The 
polarization state of the beam after interacting with a tablet is 
S’=MS, where  0 1 2 3, , ,S S S SS  and  0 1 2 3' ' , ' , ' , 'S S S SS  
are the Stokes vectors of the incident and the reflected light 
respectively. If the sample is isotropic the normalized Mueller M0 is 
highly symmetric and some of its components are zero:  
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with  cos 2 ,N   sin 2 cos ,C   and  sin 2 sin .S    
Ellipsometric angles ψ and Δ are related to the complex Fresnel 
reflection coefficients for p- and s- polarized light (rpp and rss, 
respectively) by means of  tan exp .pp
ss
r
i
r
   For more insight 
about ellipsometric techniques and the Mueller matrix see, for 
instance, references [20, 21].  
The Mueller matrix ellipsometer used for measurements was 
described in [22-23]. This instrument uses four photoelastic 
modulators (PEMs) with different frequencies to modulate the 
polarization state of light both before and after the sample [Fig. 
1(b)]. Fourier analysis of the time varying signal delivers 
simultaneously all sixteen elements of the Mueller matrix with 
high precision.  All ellipsometric measurements were done with an 
angle of incidence of 70º, using a spot size of approximately 8 mm 
x 6 mm that impinged at the center of each tablet.  The film-coated 
tablets were glued on a microscope slide and then mounted in the 
sample holder of the instrument. The selection of the target pill 
that is measured was done by moving the vertical or lateral 
translators of the sample holder.    
Our film-coated tablets can be roughly considered as a turbid 
medium in which light can be scattered consecutively several 
times before leaving the medium, thus introducing some 
depolarization. It is expected that metallic nanoparticles of 
different sizes will distinctively modify this depolarizing behavior 
[10-12]. This fact is used to discriminate among the different 
classes of film-coated tablets. We measured the Mueller matrix 
components for two film-coated tablets representative of each 
class, using the instrument described above. The measurements 
were spectroscopic beam in the range 280 to 700 nm. Results are 
presented in Fig. 2, where black, red, green and blue curves stand 
for placebo, 4, 12, and 25 nm film-coated tablets. Two film-coated 
tablets of each class have been measured.  
Despite the fact that Mueller matrix components can take values 
between -1 and 1, for the sake of readability the y-scale of the plots 
matches their respective dynamic ranges. Note that components 
m01 = m10, m22, m23 =-m23 and m33 provide distinctive information; 
m00 is, because of the normalization, equal to one and component 
m11 is nearly 1 within the considered range. The rest of the 
components are very close to zero and fluctuations can be 
considered measurement noise. Generally speaking, samples 
behave in a very close manner to isotropic materials since they 
approximately follow the polarimetric Mueller matrix model 
described in Eq. (2).    
 
Fig. 2. Mueller matrix elements [see Eq. (1)] as a function of the wavelength for nanogold particle encoded tablets. The y-scale of 
the plots matches the respective dynamic ranges of the components. Two tablets of each set were measured. Black: placebo film-
coated tablets; red: film-coated tablets with 4 nm AuNP; green: film-coated tablets with 12 nm AuNP; blue: film-coated tablets 
with 25 nm AuNP.  
The degree of polarization DoP is an effective way to describe 
the behavior of the samples with a single parameter. The DoP of a 
beam described by the Stokes vector S is defined as  
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We calculate the DoP as a function of the wavelength for several 
polarization states of the input beam represented by the following 
Stokes vectors: (1,0,0,0), (1,1,00), (1,-1,0,0), (1,0,1,0), (1,0,-1,0), 
(1,0,0,1) and (1,0,0,-1).  The eight tablets considered are taken into 
account. Results are presented in Fig. 3. In general, the DoP is 
nearly constant within the range 350-700 nm. Note that for the 
cases S=(1,0,0,1) (clockwise circularly polarized light) or 
S=(1,1,0,0) (x-direction linearly polarized light) results are noisier. 
Then, the DoP as a function of the wavelength for all possible states 
of the Stokes vector  1,cos2 ,sin 2 ,0 S  is calculated, where 
the polarization angle  ranges from 0 to 90º. The averaged value 
of the DoP (for wavelengths within the range 350 to 700 nm) is 
shown in Fig. 4. Note that the errors bars indicate the standard 
deviation of the DoP for the corresponding angle. It is apparent 
that that for angles  [20º, 35º], the DoP of the two samples that 
belong to the same class display very similar values, i.e. both curves 
nearly overlap. Moreover, the behavior of the DOP for the placebo 
and the 4 nm AuNP film-coated tablets is very similar and can 
hardly be distinguished for >40º.   
 
Fig. 3. DoP as a function of the wavelength for different 
polarization states:  Black curves: placebo film-coated tablets; 
red curves: film-coated tablets with 4 nm AuNP; green curves: 
film-coated tablets with 12 nm AuNP; Blue curves: film-
coated tablets with 25 nm AuNP. 
A possible way to circumvent errors in film-coated tablets 
classification is by using machine learning algorithms.  For 
classification purposes we take the k-nearest neighbors (kNN) 
algorithm [24]. This is a very powerful unsupervised classification 
method but relatively easy to implement. kNN tries to determine 
the class the current sample belongs to by considering the majority 
of the k closest samples of the training set. The scikit-learn library 
is used to perform calculations [25]. Classification methods require 
sufficient data to train the system: we evaluate the DoP as a 
function of the wavelength (in the range 350 to 700 nm), when the 
sample is illuminated with linearly polarized light; the polarization 
angle   ranges from 20º to 35º with a step size of 0.057º (0.001 
rad). We use a hold-out strategy to divide the dataset into training 
and test sets: the training set was generated by selecting randomly 
half of the samples of the four classes. The mean accuracy (total 
number of samples correctly classified divided by the total number 
of test samples) is used to evaluate classification capability [26]. 
The algorithm was run 1000 times using different combinations of 
samples as the training set. We set k=1. The classification accuracy 
was equal 1, so successful classification of the film-coated tablets is 
possible using the DoP estimated from the Mueller matrix analysis.
 
Fig. 4. Averaged DoP as a function of the polarization angle. 
Error bars show the standard deviation. The mean is 
calculated in the range 350-700 nm. Black dots: placebo film-
coated tablets; red dots: film-coated tablets with 4 nm AuNP; 
Green dots: film-coated tablets with 12 nm AuNP; blue dots: 
film-coated tablets with 25 nm AuNP. 
A second test using kNN algorithm was conducted. In this case, 
the DoP data set generated by four film-coated tablets, each one 
representing its corresponding class, is used to train the system 
whereas the data provided by the other film-coated tablets is used 
to test the classification. We took into account the 16 possible 
combinations. In all cases considered the classification accuracy 
was equal to 1. In conclusion, the system can be trained with the 
data obtained from a set of AuNP film-coated tablets.  
In summary, we propose using polarimetric authentication and 
verification of nano particle encoded pharmaceutical tablets. 
Experiments are presented by producing film-coated with AuNP 
as a way to detect possible counterfeiting in pharmaceutical 
tablets. Film-coated tablets become polarimetrically labeled and 
thus they can be distinguished among authentic and counterfeit 
classes of tablets. During the fabrication process, AuNP of 4, 12 and 
25 nm of size were dispersed on the coating of three different sets 
of otherwise identical film-coated tablets.  We also produced a 
fourth group of film-coated tablets that do not contain AuNP. The 
analysis of the samples was performed using a Mueller matrix 
ellipsometer able to produce information in the range 280 to 700 
nm. The information provided by this device is used to calculate 
the DoP. By means of the kNN classification algorithm we 
demonstrate that successful authentication is possible and that the 
film-coated tablets can be unambiguously distinguished without 
error. The present results show successful classification using four 
classes of tablets. More complex and realistic scenarios with a 
variety of tablets coated with multiple AuNP sizes can be 
considered as well using more powerful classification techniques 
trained with a larger number of samples. Other polarimetric 
and/or recognition approaches may be used [27]. 
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